Literature DB >> 24248535

Purification and characterization of aminoglycoside phosphotransferase APH(6)-Id, a streptomycin-inactivating enzyme.

Meseret Ashenafi1, Tatiana Ammosova, Sergei Nekhai, W Malcolm Byrnes.   

Abstract

As part of an overall project to characterize the streptomycin phosphotransferase enzyme APH(6)-Id, which confers bacterial resistance to streptomycin, we cloned, expressed, purified, and characterized the enzyme. When expressed in Escherichia coli, the recombinant enzyme increased by up to 70-fold the minimum inhibitory concentration needed to inhibit cell growth. Size-exclusion chromatography gave a molecular mass of 31.4 ± 1.3 kDa for the enzyme, showing that it functions as a monomer. Activity was assayed using three methods: (1) an HPLC-based method that measures the consumption of streptomycin over time; (2) a spectrophotometric method that utilizes a coupled assay; and (3) a radioenzymatic method that detects production of (32)P-labeled streptomycin phosphate. Altogether, the three methods demonstrated that streptomycin was consumed in the APH(6)-Id-catalyzed reaction, ATP was hydrolyzed, and streptomycin phosphate was produced in a substrate-dependent manner, demonstrating that APH(6)-Id is a streptomycin phosphotransferase. Steady-state kinetic analysis gave the following results: K(m)(streptomycin) of 0.38 ± 0.13 mM, K(m)(ATP) of 1.03 ± 0.1 mM, V(max) of 3.2 ± 1.1 μmol/min/mg, and k(cat) of 1.7 ± 0.6 s(-1). Our study demonstrates that APH(6)-Id is a bona fide streptomycin phosphotransferase, functions as a monomer, and confers resistance to streptomycin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24248535      PMCID: PMC3942886          DOI: 10.1007/s11010-013-1886-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  Prevalence of streptomycin-resistance genes in bacterial populations in European habitats.

Authors:  Leo S van Overbeek; Elisabeth M H Wellington; Sharon Egan; Kornelia Smalla; Holger Heuer; Jean-Marc Collard; Gillian Guillaume; Amalia D Karagouni; Theodora L Nikolakopoulou; Jan Dirk van Elsas
Journal:  FEMS Microbiol Ecol       Date:  2002-11-01       Impact factor: 4.194

2.  CONTROL OF GRAM-NEGATIVE BACTERIA IN EXPERIMENTAL ANIMALS BY STREPTOMYCIN.

Authors:  D Jones; H J Metzger; A Schatz; S A Waksman
Journal:  Science       Date:  1944-08-04       Impact factor: 47.728

3.  Streptomyces griseus streptomycin phosphotransferase: expression of its gene in Escherichia coli and sequence homology with other antibiotic phosphotransferases and with eukaryotic protein kinases.

Authors:  C K Lim; M C Smith; J Petty; S Baumberg; J C Wootton
Journal:  J Gen Microbiol       Date:  1989-12

4.  A second streptomycin resistance gene from Streptomyces griseus codes for streptomycin-3"-phosphotransferase. Relationships between antibiotic and protein kinases.

Authors:  P Heinzel; O Werbitzky; J Distler; W Piepersberg
Journal:  Arch Microbiol       Date:  1988       Impact factor: 2.552

Review 5.  Mechanism of bactericidal action of aminoglycosides.

Authors:  B D Davis
Journal:  Microbiol Rev       Date:  1987-09

Review 6.  Bacterial resistance to aminoglycoside antibiotics.

Authors:  J Davies; G D Wright
Journal:  Trends Microbiol       Date:  1997-06       Impact factor: 17.079

7.  Coupled spectrofluorometric assay for aminoglycoside phosphotransferases.

Authors:  M H Perlin; S C McCarty; J P Greer
Journal:  Anal Biochem       Date:  1988-05-15       Impact factor: 3.365

8.  Ecological and genetic analysis of copper and streptomycin resistance in Pseudomonas syringae pv. syringae.

Authors:  G W Sundin; C L Bender
Journal:  Appl Environ Microbiol       Date:  1993-04       Impact factor: 4.792

9.  Cloning and expression of streptomycin inactivating enzymes APH(6)-Ia and APH(6)-Id.

Authors:  A C Collins; M Ashenafi; A A Saunders; W M Byrnes
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2007-05-15       Impact factor: 1.770

10.  Tetracycline and streptomycin resistance genes, transposons, and plasmids in Salmonella enterica isolates from animals in Italy.

Authors:  Cristina Pezzella; Antonia Ricci; Elisabetta DiGiannatale; Ida Luzzi; Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

View more
  3 in total

1.  Antibiotic resistance and inhibition mechanism of novel aminoglycoside phosphotransferase APH(5) from B. subtilis subsp. subtilis strain RK.

Authors:  Rishikesh S Parulekar; Sagar S Barale; Kailas D Sonawane
Journal:  Braz J Microbiol       Date:  2019-08-10       Impact factor: 2.476

2.  Aminoglycoside-Modifying Enzymes Are Sufficient to Make Pseudomonas aeruginosa Clinically Resistant to Key Antibiotics.

Authors:  Aswin Thacharodi; Iain L Lamont
Journal:  Antibiotics (Basel)       Date:  2022-07-01

3.  Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China.

Authors:  Jun Li; Mingxiang Zou; Qingya Dou; Yongmei Hu; Haichen Wang; Qun Yan; Wen' En Liu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-05-23       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.